
Postdoctoral researcher in colorectal cancer @LabEdwards
Joined June 2022
- Tweets93
- Following81
- Followers59
- Likes444
Phimmada hatthakarnkul retweeted
An update to the Hallmarks of Cancer framework for understanding (and researching) what causes human cancers. spkl.io/6010Aqwbi
Douglas Hanahan
@CellCellPress
Phimmada hatthakarnkul retweeted
Comparative analysis of commercial Imaging-based #SpatialTranscriptomics methods
Xenium
CosMx 1k
MERSCOPE
Tissue Microarray
17 tumors + 16 normal tissues
Transcript count
Corr. with reference bulk TCGA GTEx RNAseq or scRNAseq
Segmentation (Precision Recall F1 score) Accuracy: Elongated < Sparse < Dense cells
Cell type annotation
2024 CosMx @brukerspatial protocol (vs 2023)▶️ 10-fold ⬆️sensitivity!😮
MERSOPE sensitive to RNA quality
@GoodsBrittany @NatureComms 2025
nature.com/articles/s41467-0…
Phimmada hatthakarnkul retweeted
Exciting news for rectal cancer patients - results from a Glasgow clinical trial provide new hope
heraldscotland.com/news/2513…
Phimmada hatthakarnkul retweeted
🇬🇧PRIME-RT results @ESTRO_RT today:
Durvalumab anti-PDL1+SC/LC TNT in #rectalcancer
52% of pts had CR (pCR/cCR) @ 6mth post-EOT in LARC
⬆️CR rate w SCRT-Durv - may reflect divergent immune effects of RT on TME
Privileged to be part of incredible ‘Top trials’ session#ESTRO25
Phimmada hatthakarnkul retweeted
Phimmada hatthakarnkul retweeted
Prof. Joanne Edwards' research @UofGCancerSci uses advanced models and omics to explore cancer biology and identify treatment targets.
From 2011, we funded Joanne to study whether STAT1 is a targetable tumour suppressor in #ProstateCancer
📙 Read more: prostatecanceruk.org/researc…
Phimmada hatthakarnkul retweeted
.@Katie_Robb_Glas and @McsorleyStephen are grateful to receive funding from @bowelcanceruk to investigate barriers to surveillance colonoscopy faced by people in areas with more deprivation.
We’re excited to announce we’re awarding three new research grants! 📣
These projects are focusing on improving early diagnosis of #BowelCancer. The focus on early diagnosis was chosen because the disease is treatable if caught early.
Phimmada hatthakarnkul retweeted
Happy Holidays Everyone! 🎄🎄🎄
We hope that you are all staying warm on the wind down to the winter break! ☃️🧣
‼️Check out the first issue of our newsletter for a round-up on what we have been up to recently:
gla.ac.uk/research/az/transl…
Be merry and bright! ❄️
The Edwards Lab
Phimmada hatthakarnkul retweeted
Vielen Dank, dass Sie uns haben! 🇩🇪
PhD student Sara and @INCISE_research clinical Lead Stephen McSorley were at the 4th International Conference on Cancer Prevention #ICCP2024 in Heidelberg, Germany.
Phimmada hatthakarnkul retweeted
Excellent lightning talk from PhD student Sara @IntConfCanPrev @DKFZ, reporting future adenoma risk prediction using IHC in screen detected polyps from the @INCISE_research cohort @LabEdwards @UofGMVLS
Phimmada hatthakarnkul retweeted
🎉Milestone achieved! 3000 slides scanned on @3DHISTECH_LTD P1000 for @INCISE_research! Huge thanks to our incredible collaborators @OracleBio. Shoutout to @AulaAmmar1, @mhendricks1996 & Scott Murray for their stellar work on IHC & biomarker checks!👏#ResearchCollab #Oncology
Phimmada hatthakarnkul retweeted
🌟Big news from GTRF! 🌟We’re excited to welcome our new @3DHISTECH P1000 scanner, made possible by @Beatson_Charity funding! This advanced technology will enhance histology imaging for cancer research.
Huge thanks to @LabEdwards for their support! 💙 #Technology #CancerResearch

ALT @3DHistech P1000 has the capacity of scanning 1000 slides. This equipment is very efficient for our business taking less than 1min/slide for 20x resolution scanning. It can perform 20x 40x resolution & has different RGB setting to customise the images as your preference. Fun fact: It not only does normal slides - it scans Megaslides too! #Technology #Opentocollaborate
Phimmada hatthakarnkul retweeted
🚨 We are hiring! Gd 7 PDRA position to support research on new AI-based classifiers of RT response in #rectalcancer👇
my.corehr.com/pls/uogrecruit…
Funded by Stand Up to Cancer campaign for CRUK - please get in touch!
Phimmada hatthakarnkul retweeted
You can still participate in Polyp Patrol tomorrow at the ARC 12-3!
What a first day! 🥳
The mission of INCISE is to improve bowel surveillance, so it is important for the public to understand bowel screening. 🤔
Find us tomorrow 12-3 for a chance to make your own cells and polyps! 🤩
#explorathon2024 #explorathon24 #polyps #science
Phimmada hatthakarnkul retweeted
Looking for PhD students/postdocs for my newly opened lab at the Institute of Human Biology of #Roche in Basel. We work on human lung, liver and gut #organoids. Send email + CV + motivation letter to [email protected] with header #IHB institutehumanbiology.com
Phimmada hatthakarnkul retweeted
Replying to @INCISE_research
@INCISE_research We have a unique cohort or serrated polyps with detailed histology, patients characteristics, transcriptomics and genomics @JoanneE59669325
Phimmada hatthakarnkul retweeted
Its been a week since #EdwardsLabDayOut. 😌
Although not everyone could make it, we had a fantastic time! 🌊🚤🚲
All thanks to @NamNatthamon, @phimmz, and Guang-Yu for organizing such a fun day!
📍Largs, Scotland
Phimmada hatthakarnkul retweeted
Nothing like a day by the ocean and some gusty winds with your team😌😌😌
Its been a week since #EdwardsLabDayOut. 😌
Although not everyone could make it, we had a fantastic time! 🌊🚤🚲
All thanks to @NamNatthamon, @phimmz, and Guang-Yu for organizing such a fun day!
📍Largs, Scotland
Had a great discussions thanks to my both Glasgow and Thai’s panel. What a wonderful 4 years experience!. Big thanks to everyone who support me throughout these years 😊💕
Two rounds of applause to Dr. Phimmada! One for passing her Mahidol University viva, and one for her University of Glasgow viva! Thanks to her Glasgow Viva panel @DrHeatherGJ @JbirchJ @aideenryan1 for the discussion.
Phimmada hatthakarnkul retweeted
🔬 Professor Joanne Edwards explains how she aims to change the clinical management of bowel cancer patients.
Explore this #MVLS2033 theme further -buff.ly/4cUb6iL
#DiagnosticsTherapeutics #CancerResearch












































